Patents Assigned to 2cureX A/S
  • Predicting efficacy of or resistance to treatment of colon cancer
    Patent number: 12761210
    Abstract: The invention relates to methods for predicting the efficacy and/or resistance to one or more treatment regimens comprising administration of a platinum compound in individuals suffering from colon cancer. The methods comprises providing a colon cancer biopsy from the individual, generating tumoroids thereof, and testing whether growth/viability/metabolism of said tumorids is inhibited by incubation with the platinum compounds.
    Type: Grant
    Filed: December 28, 2021
    Date of Patent: October 13, 2026
    Assignee: 2cureX A/S
    Inventors: Grith Hagel, Jacob Thastrup, Ole Thastrup